Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens

Изучение синергических и антагонистических взаимодействий в комбинациях фагов и антибиотиков против патогенов группы ESKAPE
Ashlan J. Kunz Coyne, Mirna Eshaya, Callan R. Bleick, Samantha Vader, Biswajit Kumar Biswas, Melanie Wilson, Michael V. Deschenes, Jose Alexander, Susan M. Lehman, Michael Joseph Rybak
2024-07-31

ESKAPE pathogensantimicrobial resistancecheckerboard MIC assaysphage-antibiotic combinationstime-kill analysis
ABSTRACT In the era of antimicrobial resistance, phage-antibiotic combinations offer a promising therapeutic option, yet research on their synergy and antagonism is limited. This study aims to assess these interactions, focusing on protein synthesis inhibitors and cell envelope-active agents against multidrug-resistant bacterial strains. We evaluated synergistic and antagonistic interactions in multidrug-resistant Staphylococcus aureus , Enterococcus faecium , and Pseudomonas aeruginosa strains. Phages were combined with protein synthesis inhibitors [linezolid (LZD), minocycline (MIN), gentamicin (GEN), and azithromycin (AZM)] or cell envelope-active agents [daptomycin (DAP), ceftaroline (CPT), and cefepime (FEP)]. Modified checkerboard minimum inhibitory concentration assays and 24-h time-kill analyses were conducted, alongside one-step growth curves to analyze phage growth kinetics. Statistical comparisons used one-way analysis of variance (ANOVA) and the Tukey test ( P < 0.05). In the checkerboard and 24-h time-kill analyses (TKA) of S. aureus and E. faecium , phage-LZD and phage-MIN combinations were antagonistic (FIC > 4) while phage-DAP and phage-CPT were synergistic (FIC 0.5) (ANOVA range of mean differences 0.52–2.59 log 10 CFU/mL; P < 0.001). For P. aeruginosa , phage-AZM was antagonistic (FIC > 4), phage-GEN was additive (FIC = 1), and phage-FEP was synergistic (ANOVA range of mean differences 1.04–1.95 log 10 CFU/mL; P < 0.001). Phage growth kinetics were altered in the presence of LZD and MIN against S. aureus and in the presence of LZD against a single E. faecium strain (HOU503). Our findings indicate that select protein synthesis inhibitors may induce phage-antibiotic antagonism. However, this antagonism may not solely stem from changes in phage growth kinetics, warranting further investigation into the complex interplay among strains, phage attributes, and antibiotic mechanisms affecting bacterial inhibition. IMPORTANCE In the face of escalating antimicrobial resistance, combining phages with antibiotics offers a promising avenue for treating infections unresponsive to traditional antibiotics. However, while studies have explored synergistic interactions, less attention has been given to potential antagonism and its impact on phage growth kinetics. This research evaluates the interplay between phages and antibiotics, revealing both synergistic and antagonistic patterns across various bacterial strains and shedding light on the complex dynamics that influence treatment efficacy. Understanding these interactions is crucial for optimizing combination therapies and advancing phage therapy as a viable solution for combating antimicrobial resistance.
1
In P. aeruginosa, phage–azithromycin was antagonistic, phage–gentamicin was additive (FIC = 1), and phage–cefepime was synergistic (P < 0.001).
2
In S. aureus and E. faecium, phage–linezolid and phage–minocycline combinations were antagonistic, whereas phage–daptomycin and phage–ceftaroline were synergistic (FIC 0.5; P < 0.001).
3
Phage growth kinetics changed with linezolid and minocycline against S. aureus and with linezolid against one E. faecium strain, indicating that antagonism may involve mechanisms beyond altered phage replication.
4
Synergistic combinations produced significant reductions of up to 2.59 log10 CFU/mL in S. aureus and E. faecium, and 1.04–1.95 log10 CFU/mL in P. aeruginosa.
5
The interaction outcome depends on bacterial strain, phage characteristics, and antibiotic mechanism, highlighting the need for combination-specific evaluation.
6
The study systematically evaluated phage–antibiotic interactions against multidrug-resistant Staphylococcus aureus, Enterococcus faecium, and Pseudomonas aeruginosa.

Phage–antibiotic combinations targeting multidrug-resistant ESKAPE bacterial strains, specifically Staphylococcus aureus, Enterococcus faecium, and Pseudomonas aeruginosa

Synergistic, additive, and antagonistic interactions between phages and protein-synthesis or cell-envelope-active antibiotics, including their effects on bacterial inhibition and phage growth kinetics

Publication Details
Publication Date
2024-07-31
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Ashlan J. Kunz Coyne
Mirna Eshaya
Callan R. Bleick
Samantha Vader
Biswajit Kumar Biswas
Melanie Wilson
Michael V. Deschenes
Jose Alexander
Susan M. Lehman
Michael Joseph Rybak
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%